Kyowa Hakko Kirin is rolling out the psoriasis med brodalumab this week in Japan, its first world market, but it faces a tough road ahead.

India's FMRAI union is calling for a mass strike by pharma sales reps in November as protests over working practices gather strength.

Sanofi and Regeneron’s next wannabe blockbuster is officially in regulators’ hands--but with the candidate tapped for a speedy review process, it may not stay…

More than two years after buying Merck's OTC unit and local player Dihon, bringing together three separate consumer care businesses in China remains a…

With forced price cuts for brands such as Gilead Sciences' hep C med Sovaldi already under its belt, the Japanese government is weighing others to help…

Novo Nordisk has seen its position in the Chinese diabetes market whittled away in the last couple of years, but it says new products will keep it on top.

Dr. Reddy's will sell three of Amgen's already-approved drugs in India, extending an earlier deal involving three late-stage pipeline candidates.

Japan's Otsuka is hoping that smart packaging could help one of its main pharma products maintain a hold in the marketplace.

Sun Pharma's takeover of Ranbaxy is not sitting well with some of the latter's sales reps. Hundreds are threatening an all-out strike later this…

Sales and Marketing